Series A Therapeutics Companies

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

Bioxodes is developing a portfolio of high value products derived from natural sources.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.

Inflammx Therapeutics is a biotechnology startup company.

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Gabaeron is a biopharmaceutical business that develops therapeutics for neurological illnesses based on stem cells and small chemicals.

Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.

Akamis Bio is a clinical-stage oncology company.

CILcare specializes in providing drug solutions for hearing and ear disorders.

City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

Holoclara is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.

Broad-spectrum antiviral drug development

Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.